| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.097 | 0.005 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.01 |